Efficacy and safety of pembrolizumab monotherapy in EGFR-mutant squamous cell lung cancer with PD-L1 over-expression: A case report.
- Resource Type
- journal article
- Source
- Medicine; 8/19/2022, Vol. 101 Issue 33, pe30099-e30099, 1p
- Subject
- Language
- ISSN
- 00257974